Safety, tolerability, and efficacy of brodalumab (AMG 827) in subjects with moderate to severe asthma with high bronchodilator reversibility: subgroup analysis of a randomised, double-blind, placebo-controlled, multiple-dose study

被引：0
|
作者：
Holgate, S. [1 ]
Busse, W. W. [2 ]
Kerwin, E. [3 ]
Chon, Y. [4 ]
Feng, J. [4 ]
Lin, J. [4 ]
Lin, S-L [4 ]
机构：
[1] Univ Southampton, Southampton, Hants, England
[2] Univ Wisconsin, Sch Med, Madison, WI USA
[3] Clin Res Inst Southern Oregon PC, Medford, OR USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [21] A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease
    D'Haens, Geert
    Danese, Silvio
    Davies, Martin
    Watanabe, Mamoru
    Hibi, Toshifumi
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 (05): : 746 - 756
  • [22] Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
    Low, Phillip A.
    Robertson, David
    Gilman, Sid
    Kaufmann, Horacio
    Singer, Wolfgang
    Biaggioni, Italo
    Freeman, Roy
    Perlman, Susan
    Hauser, Robert A.
    Cheshire, William
    Lessig, Stephanie
    Vernino, Steven
    Mandrekar, Jay
    Dupont, William D.
    Chelimsky, Thomas
    Galpern, Wendy R.
    [J]. LANCET NEUROLOGY, 2014, 13 (03): : 268 - 275
  • [23] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Papp, K.
    Reich, K.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Gottlieb, A. B.
    Thaci, D.
    Li, J.
    Nirula, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [24] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra E.
    Lim, Joanne
    Klekotka, Paul
    Kricorian, Greg
    Nirula, Ajay
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [25] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
    Cabrera-Rode, Eduardo
    Cubas-Duenas, Ileana
    Rodriguez Acosta, Janet
    Cruz Hernandez, Jeddu
    Conesa Gonzalez, Ana Ibis
    Gonzalez Calero, Teresa M.
    Arnold Dominguez, Yuri
    Hernandez Rodriguez, Jose
    Reyes Rodriguez, Antonio D.
    Alvarez Alvarez, Aimee
    Echevarria Valdes, Ragmila
    Jorge Espinosa, Liudmila
    Torres Belent, Onelia
    Bell Benavides, Zoila
    Senra Estevez, Elizabeth
    Abreu Rodriguez, Yanet
    del Valle Rodriguez, Juana
    Marin Julia, Silvia
    [J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [26] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
    Eduardo Cabrera-Rode
    Ileana Cubas-Dueñas
    Janet Rodríguez Acosta
    Jeddú Cruz Hernández
    Ana Ibis Conesa González
    Teresa M. González Calero
    Yuri Arnold Domínguez
    José Hernández Rodríguez
    Antonio D. Reyes Rodríguez
    Aimee Álvarez Álvarez
    Ragmila Echevarría Valdés
    Liudmila Jorge Espinosa
    Onelia Torres Belent
    Zoila Bell Benavides
    Elizabeth Senra Estévez
    Yanet Abreu Rodríguez
    Juana del Valle Rodríguez
    Silvia Marín Juliá
    [J]. BMC Complementary Medicine and Therapies, 23
  • [27] Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
    Mease, Philip J.
    Chohan, Saima
    Fructuoso, Ferran J. Garcia
    Luggen, Michael E.
    Rahman, Proton
    Raychaudhuri, Siba P.
    Chou, Richard C.
    Mendelsohn, Alan M.
    Rozzo, Stephen J.
    Gottlieb, Alice
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (09) : 1147 - 1157
  • [28] Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
    Busse, William W.
    Holgate, Stephen
    Kerwin, Edward
    Chon, Yun
    Feng, JingYuan
    Lin, Joseph
    Lin, Shao-Lee
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (11) : 1294 - 1302
  • [29] Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
    Sun, Hong
    Dodick, David W.
    Silberstein, Stephen
    Goadsby, Peter J.
    Reuter, Uwe
    Ashina, Messoud
    Saper, Joel
    Cady, Roger
    Chon, Yun
    Dietrich, Julie
    Lenz, Robert
    [J]. LANCET NEUROLOGY, 2016, 15 (04): : 382 - 390
  • [30] Clinical Efficacy and Tolerability Evaluation of Pentoxifylline in Rheumatoid ArthritisA Double-Blind, Randomised, Placebo-Controlled Study
    P. R. Usha
    M. U. R. Naidu
    Renuka Datla
    [J]. Clinical Drug Investigation, 2002, 22 : 329 - 339
12345